> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Fidelity Parent FMR Holds 5.6% Of Danaher, Certifies It Isn't Seeking Control
- URL: https://www.bullished.co/fidelity-parent-fmr-holds-5-6-of-danaher-certifies-it-isnt-seeking-control-a2d4041c/
- Published: 2026-11-05T19:09:14.000Z
- Updated: 2026-11-05T19:09:14.000Z
- Description: FMR and chairman Abigail Johnson report 39,184,954.77 shares of Danaher as of September 30, a passive position.
- Author: Matteo Parrino
- Tags: SEC Filings, DHR, Industry: Healthcare

FMR LLC, the parent of Fidelity, holds [5.6% of Danaher](https://www.sec.gov/Archives/edgar/data/0000315066/000031506626002718/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co), or 39,184,954.77 shares, as of September 30, according to a passive ownership filing (a Schedule 13G) made Thursday. Danaher, which makes instruments, consumables, software and services for biotechnology, life sciences and diagnostics, was the subject of the report, and FMR certified it did not buy the stake to influence control.

## Who holds the 39 million shares

FMR reported sole voting power over 35,309,085.54 of the shares and shared voting power over none. Chairman and CEO Abigail P. Johnson is a joint filer on the same 39,184,954.77 shares, with no voting power of her own.

FMR signed a certification that the shares were bought and are held in the ordinary course of business, not to change or influence control of [Danaher](https://www.bullished.co/tag/dhr/). The filing says one or more other persons have the right to receive dividends or sale proceeds from the stock, though no single one has more than 5% of the outstanding shares.

An [exhibit](https://www.sec.gov/Archives/edgar/data/315066/000031506626002718/exhibit99.txt?ref=bullished.co) lists the Fidelity entities behind the position, including Fidelity Management & Research Company, FIAM, Fidelity Management Trust Company and Strategic Advisers. It says Johnson family members, as predominant owners of Series B voting shares, hold 49% of the voting power of FMR.

## A stock under pressure after earnings

Danaher shares traded at $226.88 in Thursday trading, down 3.43% from the prior close, giving the company a market value of $165.2 billion.

The company's third-quarter results, reported October 21, showed higher sales and earnings than a year earlier, according to a [Yahoo Finance report](https://sg.finance.yahoo.com/news/danaher-dhr-why-drawing-fresh-101407461.html?ref=bullished.co). A [separate report](https://finance.yahoo.com/markets/stocks/articles/danaher-dhr-stock-fair-value-062023916.html?ref=bullished.co) said several brokerages have since raised price targets, clustering in roughly the $250 to $275 range, while Stifel flagged expected respiratory-testing headwinds heading into the fourth quarter.

Danaher's Cepheid unit also won [FDA clearance](https://finance.yahoo.com/healthcare/articles/danaher-dhr-wins-fda-clearance-171035506.html?.tsrc=rss&ref=bullished.co) for a hemorrhagic fever test.

[Danaher management](https://sg.finance.yahoo.com/news/danaher-dhr-why-drawing-fresh-101407461.html?ref=bullished.co) is scheduled to appear at UBS and Jefferies healthcare conferences, per Yahoo Finance.

Learn

- [What a Reverse Termination Fee Means: Who Pays When a Merger Collapses →](https://www.bullished.co/learn/reverse-termination-fee-meaning/)  
A reverse termination fee is paid by the buyer to the target if a merger fails on agreed terms. See how it differs from a break-up fee, with live deal examples.
- [How To Read A Merger Proxy: A Checklist For Shareholders Facing A Vote →](https://www.bullished.co/learn/merger-proxy-statement-how-to-read/)  
Facing a merger vote? Read the proxy in this order: price and payment, vote date and threshold, board background, synergy claims, then closing conditions.

### Sources

- [SCHEDULE 13G — FMR LLC re: DANAHER CORP (DHR)](https://www.sec.gov/Archives/edgar/data/0000315066/000031506626002718/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR
- [SCHEDULE 13G Exhibit 99](https://www.sec.gov/Archives/edgar/data/315066/000031506626002718/exhibit99.txt?ref=bullished.co) — SEC EDGAR
- [Danaher (DHR), Why Is It Drawing Fresh Attention Today?](https://sg.finance.yahoo.com/news/danaher-dhr-why-drawing-fresh-101407461.html?ref=bullished.co) — Yahoo Finance
- [Danaher (DHR) Stock Fair Value Rises After Higher Analyst Targets And Q3 Commentary](https://finance.yahoo.com/markets/stocks/articles/danaher-dhr-stock-fair-value-062023916.html?ref=bullished.co) — Yahoo Finance
- [Danaher (DHR) Wins FDA Clearance For Hemorrhagic Fever Test With Four Virus Detection](https://finance.yahoo.com/healthcare/articles/danaher-dhr-wins-fda-clearance-171035506.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [Learn Why The Bull Case For Danaher (DHR) Could Change Following FDA Test Clearance](https://finance.yahoo.com/healthcare/articles/learn-why-bull-case-danaher-111452955.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [Danaher wins FDA nod for Xpert Hemorrhagic Fever Panel (DHR) | Seeking Alpha](https://seekingalpha.com/news/4663932-danaher-wins-fda-nod-xpert-hemorrhagic-fever-panel?ref=bullished.co) — seekingalpha.com

### More on Danaher

- [Danaher's New CEO Says Growth Fell Short Of Portfolio's 'Full Potential' And Names Share Gain Her 'Report Card'](https://www.bullished.co/danahers-new-ceo-says-growth-fell-short-of-portfolios-full-potential-and-names-share-gain-ab8ddb5f/)
- [Danaher's Tax Line Swung To A $75 Million Benefit As Diagnostics Margin Fell To 21.3%](https://www.bullished.co/danahers-tax-line-swung-to-a-75-million-benefit-as-diagnostics-margin-fell-to-21-3-227fe7ca/)
- [Danaher Lifts 2026 Adjusted EPS Outlook To $8.57-$8.62 As Core Growth Ex-Respiratory Hits 5.5%](https://www.bullished.co/danaher-lifts-2026-adjusted-eps-outlook-to-8-57-8-62-as-core-growth-ex-respiratory-hits-5-baa72797/)

[All Danaher (DHR) coverage →](https://www.bullished.co/tag/dhr/)